September 18, 2014

This is a video recording of the lively panel discussion about what is exciting in cancer drug development and what is not popular in licensing, and why. Biotech and pharmaceutical consultant Linda Pullan was joined by three panelists who are business development experts from a global pharmaceutical company, a leading academic cancer center, and a top business development consulting firm. The panelists discussed theories of cancer, favorite targets and modalities, the impact of reimbursement, deal types, and more.If you are developing a cancer drug or working toward in- or out-licensing of a cancer drug, you will want to hear these perspectives. Throughout the discussion, the panelists respond to questions from the audience.

view the
the web panel recording




ShareVault’s secure document sharing solution gives pharmaceutical and biotechnology  organizations the confidence to simply and securely share sensitive documents with third parties during due diligence, product development, technology transfers, fundraising, partnering, collaborative research and other activities that require the highest level of document security.

Compared to consumer-grade solutions, ShareVault virtual data rooms offer many features that give you control and document intelligence with the highest level of document-protection and monitoring available. Learn more.